Related references
Note: Only part of the references are listed.Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence and JAK2 V617F allele burden
Eduardo Arellano-Rodrigo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Long-term management of thrombocytosis in essential thrombocythaemia
Gunnar Birgegard
ANNALS OF HEMATOLOGY (2009)
Advances in Understanding and Management of Myeloproliferative Neoplasms
Alessandro M. Vannucchi et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays Implications for Aspirin Resistance
Francesca Santilli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration
Sofie S. Hedegaard et al.
THROMBOSIS RESEARCH (2009)
Essential thrombocythemia, polycythemia vera, and myelofibrosis: Current management and the prospect of targeted therapy
Ayalew Tefferi
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Prevalence of polycythemia vera and essential thrombocythemia
Xiaomei Ma et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Increased cyclooxygenase-2 and thromboxane synthase expression is implicated in diosgenin-induced megakaryocytic differentiation in human erythroleukemia cells
C. Cailleteau et al.
ANALYTICAL BIOCHEMISTRY (2008)
Acetylation of prostaglandnin H2 synthases by aspirin is inhibited by redox cycling of the peroxidase
Manju Bala et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia
Alessandra Carobbio et al.
BLOOD (2008)
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
Valerio De Stefano et al.
HAEMATOLOGICA (2008)
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
Francesco Passamonti et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease
Sasidhar Guthikonda et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Mechanisms of disease:: Platelet activation and atherothrombosis
Giovanni Davi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelotibrosis: recommendations from an ad hoc international expert panel
Ayalew Tefferi et al.
BLOOD (2007)
Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin
S. Guthikonda et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients
N. Gangat et al.
LEUKEMIA (2007)
Pharmacodynamic of cyclooxygenase inhibitors in humans
Marta L. Capone et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Leukocytosis, JAK2(V617F) Mutation, and Hemostasis in Myeloproliferative Disorders
Marina Marchetti et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2007)
Constant detection of cyclooxygenase 2 in terminal stages of myeloid maturation
Claudio Tripodo et al.
ACTA HAEMATOLOGICA (2007)
Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia
Andrew I. Schafer
BLOOD (2006)
Drug therapy -: Low-dose aspirin for the prevention of atherothrombosis
C Patrono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia
CN Harrison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis
N Tanaka et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Efficacy and safety of low-dose aspirin in polycythemia vera
R Landolfi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Expression of cox-2, tie-2 and glycodelin by megakaryocytes in patients with chronic myeloid leukaemia and polycythaemia vera
E Zetterberg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets
B Rocca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)